Qtron Investments LLC Zai Lab LTD Transaction History

Qtron Investments LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 16, 2022	SELL	$54.9 - $105.21 $322,372 - $617,793	-5,872 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$125.11 - $180.0 $734,645 - $1.06 Million	5,872 New	5,872 $1.04 Million
Q1 2021 May 13, 2021	SELL	$126.27 - $191.71 $1.93 Million - $2.93 Million	-15,292 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$81.94 - $135.34 $231,808 - $382,876	2,829 Added 22.7%	15,292 $2.07 Million
Q3 2020 Nov 12, 2020	SELL	$73.3 - $89.48 $18,325 - $22,370	-250 Reduced 1.97%	12,463 $1.04 Million
Q2 2020 Aug 13, 2020	BUY	$48.82 - $82.53 $620,648 - $1.05 Million	12,713 New	12,713 $1.04 Million

146

53M

103K

439K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $3.57B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Qtron Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Qtron Investments LLC with notifications on news.